Trial Evaluating Safety, Tolerability and Immune Response of AG-707
NCT00231049
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Genital Herpes
Interventions
DRUG:
AG-707
Sponsor
Agenus Inc.